Organization
James Rubenstein
2 clinical trials
Clinical trial
A Phase I/II Study of Tafasitamab Plus Lenalidomide in Relapsed CNS LymphomaStatus: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
Pilot Study of Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS LymphomaStatus: Recruiting, Estimated PCD: 2025-03-31